Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
β-Glucuronidase/hCAII-IN-1
Cat. No.:
OB0425LY-178
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
β-Glucuronidase/hCAII-IN-1 is an inhibitor targeting beta-glucosidase and human carbonic anhydrase II (hCA II).
Synonyms:
2816080-17-6; β-Glucuronidase/hCAII-IN-1; β-Glucuronidase/hCAII-IN1
CAS No.:
2816080-17-6
Compound CID:
164887562
Formula:
C30H21NO9
Formula Weight:
539.49
Specification
Target:
Carbonic anhydrase; β-glucuronidase
Pathway:
Metabolic enzyme/Protease
Storage:
Storage at -20°C.
Applications:
β-Glucuronidase/hCAII-IN-1 can be used to study mechanisms related to drug metabolism, tumor biology, and inflammatory responses.
